A mouse kindling model of perimenstrual catamenial epilepsy

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 3, 2012, Pages 784-793

  Reddy, Doodipala Samba ^a   Gould, Jordan ^a   Gangisetty, O ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; 4 AMINOBUTYRIC ACID A RECEPTOR DELTA; BENZODIAZEPINE; DIAZEPAM; FINASTERIDE; MESSENGER RNA; NEUROSTEROID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CATAMENIAL EPILEPSY; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HIPPOCAMPUS; KINDLING; LUTEAL PHASE; MENSTRUAL CYCLE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID BLOOD LEVEL; STEROIDOGENESIS;

5-ALPHA REDUCTASE INHIBITORS; ANIMALS; DIAZEPAM; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; FINASTERIDE; GONADOTROPINS; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MENSTRUAL CYCLE; MICE; MICE, INBRED C57BL; PREGNANOLONE; PROGESTERONE; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GABA-A; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84861563818     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.192377     Document Type: Article

References (55)

1. Bazán AC, Montenegro MA, Cendes F, Min LL, and Guerreiro CA (2005) Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy. Arq Neuropsiquiatr 63:751-756. (Pubitemid 41494493)
2. Belelli D, Casula A, Ling A, and Lambert JJ (2002) The influence of subunit composition on the interaction of neurosteroids with GABAA receptors. Neuropharmacology 43:651-661. (Pubitemid 35279573)
3. Brooke DA, Orsi NM, Ainscough JF, Holwell SE, Markham AF, and Coletta PL (2007) Human menopausal and pregnant mare serum gonadotrophins in murine superovulation regimens for transgenic applications. Theriogenology 67:1409-1413. (Pubitemid 46621075)
4. Dusková M, Hill M, Hanus M, Matousková M, and Stárka L (2009) Finasteride treatment and neuroactive steroid formation. Prague Med Rep 110:222-230.
5. Follesa P, Serra M, Cagetti E, Pisu MG, Porta S, Floris S, Massa F, Sanna E, and Biggio G (2000) Allopregnanolone synthesis in cerebellar granule cells: roles in regulation of GABAA receptor expression and function during progesterone treatment and withdrawal. Mol Pharmacol 57:1262-1270. (Pubitemid 30354400)
6. Franklin KBJ and Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates, 1st ed, Academic Press, New York.
7. Gangisetty O and Reddy DS (2009) The optimization of TaqMan real-time RT-PCR assay for transcriptional profiling of GABA-A receptor subunit plasticity. J Neurosci Methods 181:58-66.
8. Gangisetty O and Reddy DS (2010) Neurosteroid withdrawal regulates GABA-A receptor α4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway. Neuroscience 170:865-880.
9. Goddard GV, McIntyre DC, and Leech CK (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295-330.
10. A receptor subunit levels in association with increased anxiety in the female rat. Brain Res 910:55-66.
11. Herzog AG, Fowler KM, Sperling MR, Liporace JD, Kalayjian LA, Heck CN, Krauss GL, Dworetzky BA, Pennell PB, and Progesterone Trial Study Group (2011) Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia 52:1843-1848.
12. Herzog AG and Frye CA (2003) Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 53:390-391. (Pubitemid 36258643)
13. Herzog AG, Harden CL, Liporace J, Pennell P, Schomer DL, Sperling M, Fowler K, Nikolov B, Shuman S, and Newman M (2004) Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 56:431-434. (Pubitemid 39166564)
14. Herzog AG, Klein P, and Ransil BJ (1997) Three patterns of catamenial epilepsy. Epilepsia 38:1082-1088. (Pubitemid 27424151)
15. Hosie AM, Wilkins ME, and Smart TG (2007) Neurosteroid binding sites on GABAA receptors. Pharmacol Ther 116:7-19. (Pubitemid 47398919)
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
17. Joshi S, Rajasekaran K, and Kapur J (2011) GABAergic transmission in temporal lobe epilepsy: the role of neurosteroids. Exp Neurol http://dx.doi.org/10.1016/j.expneurol.2011.10.028.
18. Lawrence C, Martin BS, Sun C, Williamson J, and Kapur J (2010) Endogenous neurosteroid synthesis modulates seizure frequency. Ann Neurol 67:689-693.
19. Maguire J and Mody I (2007) Neurosteroid synthesis-mediated regulation of GABAA receptors: relevance to the ovarian cycle and stress. J Neurosci 27:2155-2162. (Pubitemid 46340948)
20. Maguire J and Mody I (2008) GABAAR plasticity during pregnancy: relevance to postpartum depression. Neuron 59:207-213. (Pubitemid 352033688)
21. Maguire JL, Stell BM, Rafizadeh M, and Mody I (2005) Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8:797-804. (Pubitemid 43085847)
22. Mascia MP, Biggio F, Mancuso L, Cabras S, Cocco PL, Gorini G, Manca A, Marra C, Purdy RH, Follesa P, et al. (2002) Changes in GABAA receptor gene expression induced by withdrawal of, but not by long-term exposure to, ganaxolone in cultured rat cerebellar granule cells. J Pharmacol Exp Ther 303:1014-1020. (Pubitemid 35424384)
23. Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, et al. (1999) Attenuated sensitivity to neuroactive steroids in γ-aminobutyrate type A receptor δ-subunit knockout mice. Proc Natl Acad Sci U S A 96:12905-12910. (Pubitemid 29513601)
24. Möhler H, Fritschy JM, and Rudolph U (2002) A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2-8. (Pubitemid 34028501)
25. Moran MH and Smith SS (1998) Progesterone withdrawal I: pro-convulsant effects. Brain Res 807:84-90. (Pubitemid 29005239)
26. Mtchedlishvili Z, Bertram EH, and Kapur J (2001) Diminished allopregnanolone enhancement of GABAA receptor currents in a rat model of chronic temporal lobe epilepsy. J Physiol 537:453-465. (Pubitemid 33130502)
27. Mukai Y, Higashi T, Nagura Y, and Shimada K (2008) Studies on neurosteroids XXV. Influence of a 5α-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism. Biol Pharm Bull 31:1646-1650.
28. Pack AM, Reddy DS, Duncan S, and Herzog A (2011) Neuroendocrinological aspects of epilepsy: important issues and trends in future research. Epilepsy Behav 22:94-102.
29. Peng Z, Huang CS, Stell BM, Mody I, and Houser CR (2004) Altered expression of the δ subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J Neurosci 24:8629-8639. (Pubitemid 39313785)
30. Quigg M, Smithson SD, Fowler KM, Sursal T, Herzog AG, and NIH Progesterone Trial Study Group (2009) Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 73:223-227.
31. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
32. Reddy DS (2009) The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 85:1-30.
33. Reddy DS (2011) Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front Endocrinol 2:1-11.
34. Reddy DS, Castaneda DC, O'Malley BW, and Rogawski MA (2004) Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 310:230-239. (Pubitemid 38812716)
35. Reddy DS, Kim HY, and Rogawski MA (2001) Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42:328-336. (Pubitemid 32275911)
36. Reddy DS and Mohan A (2011) Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors. J Neurosci 31:650-658.
37. Reddy DS and Rogawski MA (2001) Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42:337-344. (Pubitemid 32275912)
38. Reddy DS and Rogawski MA (2009) Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 6:392-401.
39. Reddy DS and Zeng YC (2007) Effect of neurosteroid withdrawal on spontaneous recurrent seizures in a rat model of catamenial epilepsy. FASEB J 21:885.14.
40. Scharfman HE, Goodman JH, Rigoulot MA, Berger RE, Walling SG, Mercurio TC, Stormes K, and Maclusky NJ (2005) Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp Neurol 196:73-86. (Pubitemid 41416649)
41. Scharfman HE and MacLusky NJ (2006) The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 47:1423-1440. (Pubitemid 44393854)
42. Shen H, Gong QH, Yuan M, and Smith SS (2005) Short-term steroid treatment increases δ GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 49:573-586. (Pubitemid 41208279)
43. Smith SS and Gong QH (2005) Neurosteroid administration and withdrawal alter GABAA receptor kinetics in CA1 hippocampus of female rats. J Physiol 564:421-436. (Pubitemid 40585043)
44. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, and Li X (1998a) GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392:926-930. (Pubitemid 28232064)
45. Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA, and Hsu FC (1998b) Withdrawal from 3α-OH-5α -pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor α4-subunit in association with increased anxiety. J Neurosci 18:5275-5284. (Pubitemid 28311944)
46. Smith SS, Shen H, Gong QH, and Zhou X (2007) Neurosteroid regulation of GABAA receptors: Focus on the α4 and δ subunits. Pharmacol Ther 116:58-76. (Pubitemid 47391031)
47. Stell BM, Brickley SG, Tang CY, Farrant M, and Mody I (2003) Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δsubunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100:14439-14444. (Pubitemid 37499255)
48. Sun C, Mtchedlishvili Z, Erisir A, and Kapur J (2007) Diminished neurosteroid sensitivity of synaptic inhibition and altered location of the α4-subunit of GABAA receptors in an animal model of epilepsy. J Neurosci 27:12641-12650. (Pubitemid 350127828)
49. Sur C, Farrar SJ, Kerby J, Whiting PJ, Atack JR, and McKernan RM (1999) Preferential coassembly of α4 and γ subunits of the γ-aminobutyric acid A receptor in rat thalamus. Mol Pharmacol 56:110-115. (Pubitemid 29309818)
50. Tuveri A, Paoletti AM, Orrù M, Melis GB, Marotto MF, Zedda P, Marrosu F, Sogliano C, Marra C, Biggio G, et al. (2008) Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy. Epilepsia 49:1221-1229. (Pubitemid 351991389)
51. Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, and Whiting PJ (1996) Functional characterization of human γ-aminobutyric acid A receptors containing the α4 subunit. Mol Pharmacol 50:670-678. (Pubitemid 26303601)
52. Wafford KA, van Niel MB, Ma QP, Horridge E, Herd MB, Peden DR, Belelli D, and Lambert JJ (2009) Novel compounds selectively enhance δ subunit containing GABA A receptors and increase tonic currents in thalamus. Neuropharmacology 56:182-189.
53. Whiting P, Wafford KA, and McKernan RM (2000) Pharmacologic subtypes of GABAA receptors based on subunit composition, in GABA in the Nervous System: The View at Fifty Years (Martin DL and Olsen RW eds) pp 113-126, Lippincott Williams & Wilkins, Philadelphia.
54. A receptors containing the δ subunit. J Neurosci 22:1541-1549.
55. Zhang N, Wei W, Mody I, and Houser CR (2007) Altered localization of GABAA receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 27:7520-7531. (Pubitemid 47066583)